Loading clinical trials...
Loading clinical trials...
Dostarlimab belongs to a class of drugs called PD-1 inhibitors that use your own immune system to treat cancer (immunotherapy). It is designed to stop cancer from growing by helping your immune system...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
NCT04907643 · Cancer Pain, Visceral Pain, and more
NCT05194878 · Colon Cancer Stage II, Colon Cancer Stage III
NCT07167147 · Colon Cancer, Colon Adenocarcinoma, and more
NCT04488159 · Colon Cancer Stage III
NCT04342676 · Colon Cancer Stage III
UZLeuven
Leuven
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions